Magellan Asset Management Ltd lessened its stake in HCA Healthcare Inc (NYSE:HCA) by 2.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,753,313 shares of the company’s stock after selling 255,420 shares during the period. HCA Healthcare makes up about 5.8% of Magellan Asset Management Ltd’s holdings, making the stock its 8th biggest holding. Magellan Asset Management Ltd owned 3.71% of HCA Healthcare worth $1,774,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently added to or reduced their stakes in the business. Lee Financial Co grew its stake in HCA Healthcare by 25.9% in the 3rd quarter. Lee Financial Co now owns 1,800 shares of the company’s stock worth $250,000 after buying an additional 370 shares in the last quarter. Kendall Capital Management grew its stake in HCA Healthcare by 5.2% in the 3rd quarter. Kendall Capital Management now owns 8,250 shares of the company’s stock worth $1,148,000 after buying an additional 405 shares in the last quarter. Brown Advisory Inc. grew its stake in HCA Healthcare by 14.3% in the 3rd quarter. Brown Advisory Inc. now owns 3,275 shares of the company’s stock worth $455,000 after buying an additional 409 shares in the last quarter. Smithfield Trust Co. grew its stake in HCA Healthcare by 41.2% in the 3rd quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock worth $196,000 after buying an additional 410 shares in the last quarter. Finally, Motley Fool Asset Management LLC grew its stake in HCA Healthcare by 12.5% in the 2nd quarter. Motley Fool Asset Management LLC now owns 3,720 shares of the company’s stock worth $382,000 after buying an additional 412 shares in the last quarter. 69.94% of the stock is owned by institutional investors and hedge funds.
In related news, SVP Kathryn A. Torres sold 820 shares of the company’s stock in a transaction on Tuesday, November 13th. The shares were sold at an average price of $142.36, for a total transaction of $116,735.20. Following the completion of the sale, the senior vice president now directly owns 4,237 shares in the company, valued at approximately $603,179.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael S. Cuffe sold 5,196 shares of the company’s stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total transaction of $709,357.92. The disclosure for this sale can be found here. Insiders have sold a total of 16,763 shares of company stock valued at $2,346,147 over the last quarter. 2.80% of the stock is currently owned by company insiders.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm had revenue of $11.45 billion during the quarter, compared to analyst estimates of $11.29 billion. During the same period in the previous year, the business posted $1.13 EPS. The business’s quarterly revenue was up 7.1% on a year-over-year basis. On average, research analysts predict that HCA Healthcare Inc will post 9.34 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 0.99%. HCA Healthcare’s dividend payout ratio is currently 21.24%.
A number of equities analysts have commented on the stock. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, November 14th. Barclays initiated coverage on shares of HCA Healthcare in a report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 price objective for the company. UBS Group initiated coverage on shares of HCA Healthcare in a report on Thursday, November 15th. They issued a “buy” rating and a $162.00 price objective for the company. Robert W. Baird boosted their price objective on shares of HCA Healthcare from $130.00 to $150.00 and gave the stock a “positive” rating in a report on Thursday, September 20th. Finally, Argus boosted their price objective on shares of HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and a consensus target price of $144.15.
COPYRIGHT VIOLATION WARNING: This piece was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2018/12/06/hca-healthcare-inc-hca-shares-sold-by-magellan-asset-management-ltd.html.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: Different Types of Derivatives
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.